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C'est la vie
Life is full of dynamism and ever evolving. There are 
entities that are tangible and within reach. Yet there are 
entities that are less tangible and evasive, such as love. We 
may leave a few sparkles along our path. It seems never 
ending until one day we suddenly realise that we have to 
face our eventual destiny. There are times when we have 
to choose between two paths and you never know 
whether you have made the right choice. There is no 
turning back. 
I try to assimilate all these feelings into this artwork 
created from artistic rendering of 3D computed 
tomography (CT). It is a virtual endoscopic view looking 
downwards inside the upper part of a Zenith bifurcated 
abdominal aortic stent graft that has been implanted into a 
patient suffering from abdominal aortic aneurysm using 
minimally invasive surgery. The openings to the upper 
ends of the two limbs of the stent graft can be seen in the 
centre.
MBBS(HK), FRCR(UK), 
FHKCR, FHKAM(Radiology)
Consultant Radiologist, Radiology Department, 
Pamela Youde Nethersole Eastern Hospital, 
Hong Kong
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Minimally invasive surgery (MIS) performed through small incisions 
reduces the trauma of wound access, improves the outcomes and 
hastens the recovery of many operative procedures. The advancement 
in technical skills and equipment innovation prompt the development 
of various surgical approaches in the management of different 
diseases entities.  In the last decade, the indications and applicability 
of minimally invasive technique continue to broaden.  This issue of 
the Medical Diary examines the recent advances in the minimally 
invasive surgical approach to a variety of disease conditions, ongoing 
areas of controversy, and future directions.
Laparoscopic colectomy for certain colorectal conditions, from what 
was initially regarded as a highly specialised operation performed 
only by a few enthusiastic surgeons, has evolved to become a 
standard procedure in many centres throughout the world.  
Nowadays, MIS has also been gradually incorporated into the clinical 
pathway of rectal cancer management.
Minimally invasive locoregional surgical treatment has been 
advocated for patients with early rectal cancers to achieve the same 
oncological clearance with less morbidity and better functional 
outcomes than major ablative surgery.  Transanal endoscopic 
operation (TEO) was developed by incorporating with the existing 
laparoscopic instruments to perform endoluminal excision of early 
invasive cancers or pre-malignant lesions in the rectum.
The authors in this issue also address the recent development and 
various minimally invasive techniques for thyroid and parathyroid 
surgery.  Technical pearls in laparoscopic myomectomy for uterine 
fibroids are thoroughly described in another section.
Undoubtedly, minimally invasive surgery revolutionised and became 
an integral part of surgical practice in the last two decades.  
Notwithstanding increasing number of minimally invasive 
procedures will be routinely applied for patient care in the foreseeable 
future, open surgery will continue to play a complementary role in 
managing patients who are not suitable for minimally invasive 
surgery or when conversion becomes necessary.
Dr. PDr. Wing-tai SIU Dr. Angus CW CHAN
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The development of minimally invasive surgery (MIS) in
colorectal disease began with the first report of
laparoscopic assisted colectomy in 19911. There is now a
wealth of evidence indicating the laparoscopic approach
confers definite short term benefits to patients2,3. Even for
colorectal cancer, a common malignant condition
worldwide, evidence from randomised trials and large
prospective studies fail to demonstrate any detriment in
oncological parameters such as disease recurrence and
patient's survival consequent to a laparoscopic
approach2. As oncological feasibility is no longer a
concern, MIS is increasingly developed and practised in
patients with various colorectal conditions. This article
attempts to summarise the recent development of MIS in
the field of coloproctology.
MIS for Rectal Cancer
As dissection deep down in the pelvis is technically
demanding, early reports on laparoscopic rectal cancer
surgery were dominated by high anterior resection (i.e.
resection for tumours around rectosigmoid junction) and
sphincter-ablating resection (i.e. abdomino-perineal
resection)4-6; in the latter case the lateral or
circumferential margin is usually dictated by the perineal
surgeon rather than the laparoscopic surgeon. Progress
in technology and skills, however, has finally led to the
extension of MIS techniques to distal rectal cancer with
sphincter preservation7. Although the number of
randomised studies is still limited, the available evidence
from large prospective series demonstrates its safety in
experienced hands and an oncological clearance
comparable to that of the open counterpart8-12.
In the last decade, MIS has been gradually incorporated
into the clinical pathway of rectal cancer management.
Investigators have shown that MIS in patients with prior
neoadjuvant chemo-irradiation is safe and carries similar
short term benefits as in patients without chemo-
irradiation13. Even for tumour within 5cm from the anal
verge, successful sphincter-preserving excision has been
described using a combined laparoscopic and transanal
technique14.
MIS in Obstructive Colorectal Tumours
Like other advanced laparoscopic procedures,
laparoscopic colectomy was only described and practised
in elective, "cold" cases before the turn of the century.
The presence of intestinal obstruction, a common acute
s u r g i c a l e m e r g e n c y c o m p l i c a t i n g
colorectal malignancy, was generally considered as a
contraindication for laparoscopic approach owing to
limited access and poor exposure as a result of
distended bowel. The advent of self-expanding
endoluminal prosthesis (SEMS)15, yet another
minimally invasive 'device', provided a logical solution
and had tremendous impact in this surgical scene.
Initially used as a palliative alternative for treating
inoperable colon cancer, SEMS was subsequently used
to decompress the acutely obstructed colon and serve as
a 'bridge' to subsequent elective, laparoscopic resection.
A recent randomised controlled study focusing on this
combined, 'endo-laparoscopic' approach was just
finished, and the results suggested significantly more
patients in the 'endo-laparoscopic' group (as compared
to conventional group who received emergency
laparotomy) underwent successful one-stage operation,
with fewer patients ending up in permanent stoma16.
Most importantly, this 'endo-laparoscopic' approach
allows patients with acute malignant large bowel
obstruction to enjoy the full benefits of minimally
invasive surgery.
In another prospective study SEMS was also found to
be useful in patients with locally advanced, stenotic
rectal cancer, in whom neoadjuvant chemo-irradiation
is planned17. These patients might have otherwise
required temporary faecal diversion before definitive
surgery for fear of impending obstruction aggravated
by radiotherapy.
NOTES and Robotics in Colorectal
Surgery
Clearly much of the development in MIS is brought
about by advancement in technology. For instance,
hand-assisted devices18 were developed with a view to
shorten operating time and to facilitate dissection in
locally advanced, bulky tumours, though data from the
literature so far remain conflicting19,20. Possibly inspired
by transanal endoscopic microsurgery championed by
Buess21, investigators have tried to develop other kinds
of natural orifice transluminal endoscopic surgery
(NOTES)22,23. Some of these procedures involve a
'hybrid' technique, combining laparoscopic and
transluminal techniques; the first report of using this
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kind of hybrid technique to perform 'incisionless'
colectomy with intra-corporeal anastomsis in humans
was just lately reported24. At the same time there is a
recent enthusiasm for transanal endoscopy operation
(TEO), as the new device is system-compatible with
most MIS suites. This minimally invasive technique
is suitable for benign tumours or early invasive cancer
in the rectum.
Another recent development in this field related to
technology is robotic-assisted colorectal resection.
Hashizume et al from Japan were the first to publish
their experience with telerobotic-assisted colorectal
resections in 200225. The first Da Vinci surgical system
in China was installed in November 2005 in Hong
Kong, with the first telerobotic-assisted laparoscopic
abdomino-perineal resection performed in August
200626. So far 5 centres in Hong Kong have installed or
are planning to install the robotic system. Undoubtedly,
the system can benefit the surgeons by providing
excellent 3-D vision and ergonomics, but at the expense
of inferior tactile feedback. Whether these benefits can
be translated into better patient outcomes in a cost-
effective way still needs further evaluation.
Conclusion
Minimally invasive colorectal surgery has gone a long
way since 1991. As we unfold the history, laparoscopic
colectomy, from what initially a highly specialised
operation performed only by a small group of
privileged surgeons in research or university centres,
has evolved to become now a more or less standard
procedure in many centres throughout the world. The
development was further catalysed by progress in
technology, which has brought in new elements and
concepts of MIS besides laparoscopy, as well as
revolutionised significantly the management of certain
colorectal conditions. The indication and applicability of
MIS technique continue to broaden.
Minimally invasive colorectal surgery will continue to
flourish in the coming decades. This is reflected by the
establishment of various endo-laparoscopic operating
suites27, robotic surgery centres, and training centres on
laparoscopic surgery and NOTES. The next generation
of colorectal surgeons will be entering a new era - the
era of endo-laparoscopic surgery and robotic-assisted
laparoscopic surgery. And this will be soon
approaching.
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MCHK CME Programme Self-assessment Questions
Please read the article entitled "Recent Development in Minimally Invasive Colorectal Surgery" by Dr. CC CHUNG
and complete the following self-assessment questions. Participants in the MCHK CME Programme will be awarded 1
CME credit under the Programme for returning completed answer sheets via fax (2865 0345) or by mail to the
Federation Secretariat on or before 31 July 2009. Answers to questions will be provided in the next issue of The Hong
Kong Medical Diary.
In treating colorectal cancer, laparoscopic approach is advantageous over open surgery in terms of oncological
outcomes.
The main benefit of laparoscopic colectomy over open surgery is that it is associated with better short term
outcomes in terms of patient recovery.
Data from multiple, large-scale randomised trials have confirmed laparoscopic excision for rectal cancers results
in equivalent or better oncological clearance when compared to open surgery.
Patients with locally advanced rectal cancer requiring neoadjuvant radiotherapy should be excluded from
laparoscopic technique after neoadjuvant treatment.
Abdomino-perineal resection (APR) is recommended for all rectal adenocarcinomas within 5cm from the anal
verge.
Self-expanding endoluminal prosthesis (SEMS) is only used as a palliative treatment for inoperable colorectal
cancers.
SEMS can help to relieve acute obstruction in patients with obstructing colonic cancer, and allows these patients
to undergo elective laparoscopic excision under full bowel preparation at a subsequent stage.
Hand-assisted devices can greatly help shorten operative time during laparoscopic colectomy.
TEO provides a good alternative for poor risk patients suffering from early rectal cancers.
Robotic system provides better 3-D vision, ergonomics, as well as tactile feedback when compared to
laparoscopic surgery.
1.
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4.
5.
6.
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9.
10.
Questions 1-10: Please answer T (true) or F (false)
Please return the completed answer sheet to the Federation Secretariat on or before 31 July 2009 for
documentation. 1 CME point will be awarded for answering the MCHK CME programme (for non-specialists)
self-assessment questions.
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Introduction
Since the 1980s, minimally invasive surgical techniques
have attracted immense interest in all surgical
specialties, including abdominal, thoracic and most
recently head and neck surgery. This article aims at
reviewing the emergence of minimally invasive
thyroidectomy (MIT) and parathyroidectomy (MIP) and
their applications to benign thyroid and parathyroid
diseases respectively. For the purpose of this review,
MIT and MIP will be considered separately as they deal
with different pathologies.
MIT
The conventional thyroidectomy by making a skin
crease incision in the anterior neck just over the thyroid
gland has been the most efficacious way of treating a
variety of thyroid pathologies as it provides good direct
surgical access to facilitate safe dissection and is
associated with low morbidity in experienced hands.
However, some patients are still left with a relatively
long scar in the neck. Furthermore, the majority of
patients are women and they are understandably
concerned about the aesthetic appearance of the scar. As
a result, there has been an immense interest among
thyroid surgeons to make smaller neck incisions or even
to make "invisible" incisions (i.e. incisions outside the
neck such that they are covered by clothing). The
concept of MIT really gained momentum in 1996 when
Gagner et al. performed a totally endoscopic subtotal
parathyroidectomy for a 37 year old man suffering from
familial hyperparathyroidism.1 Although the operation
took over 5 hours, it was a success. Since then, a variety
of MIT techniques has been described. They can be
grouped into two broad approaches with each having
their own advantages and disadvantages and they are:
The Cervical / Direct Approaches
These involve placing small, almost stab-like incisions
in the anterior neck. The operating space is usually
created by blunt dissection and maintained either with
low pressure (6-8mmHg) CO2 insufflation or by
external skin retraction. Conventional laparoscopic
instruments are often used. These approaches come in
different forms and under different names. They
include anterior cervical approach, lateral cervical
approach (Picture 1) and video-assisted approach
(Picture 2). The main advantages are the direct access to
the gland and shorter neck incisions (usually < 1.5 to
2cm). To date, all published series reported less
postoperative pain, better cosmesis and shorter hospital
stay.2,3 However, since incisions are made in the neck,
for some, they remain "visible" and are prone to
hypertrophy / keloid. Furthermore, some surgeons
would argue that given the strict selection criteria used
such as nodule size　3cm in diameter or thyroid
volume　30ml, an open approach using a similar length
incision is also possible.4 This partly led some to pursue
the extracervical / indirect approaches.
The Extracervical / Indirect Approaches
These involve placing incisions outside the neck.
Depending on preference and experience, some prefer
making them in the axilla or chest while others prefer
both. Nonetheless, extensive dissection under the skin
Minimally Invasive Thyroid and
Parathyroid Surgery
Dr. Brian HH LANG
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Picture 1: Total endoscopic thyroid lobectomy using the
lateral approach
Picture 2: Video-assisted thyroid surgery with central
skin incision
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and subcutaneous layer is inevitable because incisions 
are made away from the thyroid gland. As a result, 
some authors reported prolonged paresthesia under the 
flap and muscle stiffness. In terms of the technique, 
similar to the cervical approaches, the operating space is 
maintained either by CO2 insufflation (Picture 3) or 
external retraction by specially designed skin retractors 
(Picture 4). Undoubtedly, the operation is technically 
more demanding because of the limited operating space 
and is therefore associated with a significant learning 
curve.5 However, having said so, several large series 
have been reported in various Asian countries with 
favourable outcomes.6-8 This approach has yet to 
become standard, particularly in the West. The main 
controversy lies in the fact that these procedures 
involve extensive dissection (and therefore, the name 
"MIT" might be inappropriate) and are often performed 
for "softer" indications.9 Nevertheless, the procedure is 
technically feasible and will no doubt have a promising 
role in the future as some patients will continue to 
demand a scarless (in the neck) procedure. 
MIP
In comparison to MIT, MIP has been better accepted 
and less controversial. It is the treatment of choice for 
patients diagnosed with primary hyperparathyroidism 
or pHPT due to solitary parathyroid adenoma. Again, 
they come in a variety of forms including total 
endoscopic approach, video-assisted approach, radio-
guided approach and mini-incision approach (Picture 5) 
but in principle, they are similar as they all involve 
operating through a small neck incision and excising one 
single abnormal parathyroid gland without exposing the 
other 3 parathyroid glands. This is made possible 
because over 80-90% of patients with pHPT suffer from a 
solitary parathyroid adenoma and therefore by removing 
it, they are potentially cured of their disease. MIP is an 
operation associated with low morbidity and with a high 
success rate (>95%) so long as the operating surgeon is 
meticulous, familiar with the anatomy and experienced. 
However, unlike the traditional open method where all 4 
parathyroid glands are explored, MIP must have 
accurate preoperative localisation of the abnormal 
parathyroid gland before it can be attempted. This is 
because in MIP, the operating surgeon would not have 
the benefit of examining the other 3 parathyroid glands 
and therefore, there is a possibility of missing underlying 
multiglandular disease such as double adenomas or 4-
gland hyperplasia. In our experience, over 70% with 
newly diagnosed pHPT will be eligible for MIP because 
of a positive preoperative localisation by Tc99m 
sestamibi and /or ultrasound (Picture 6).10  To further 
improve the surgical success of MIP and to minimise the 
possibility of persistent or recurrent HPT after MIP, some 
have advocated the use of a variety of surgical adjuncts 
such as radioguided probe, quick intraoperative 
parathyroid hormone assay at the time of operation but 
to date, their routine use remains questionable because of 
the marginal benefit and the high "cost to benefit" ratio. 
Nevertheless, MIP with or without the use of adjuncts 
when performed in experienced hands has an equivalent 
success rate of greater than 95% as the conventional 4-
gland exploration and has all the benefits one expects 
from minimally invasive surgery.
Conclusions
Increasing variety of MIT techniques have been reported 
in the literature. Both standard open thyroidectomy and 
MIT will continue to complement each other in the future 
but the question of whether MIT will become the 
standard approach in the future remains to be seen. On 
the other hand, various MIP techniques have become 
accepted as a standard procedure for pHPT caused by a 
localised solitary parathyroid adenoma.
Picture 3: Trans-axillary thyroidectomy with CO2
insufflation
Picture 5: Open mini-incision parathyroidectomy 
Picture 4: Gasless trans-axillary thyroidectomy 
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Picture 6: An unequivocal positive localisation of a
solitary left parathyroid adenoma by Tc99m sestamibi
scan
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Background
In 2006, colorectal cancer has become the 2nd
commonest cancer in Hong Kong. Despite significant
advancement in surgical techniques and
chemotherapeutic agents in the last decade, more than
40% of the patients still died from the disease1.
Moreover, there was an observed increasing trend of
the disease in the last ten years (Figure 1).
Radical surgical operation is regarded as the good
standard treatment for carcinomas of the rectum.2-5 A
multicentre Dutch study has shown that a properly
performed total mesorectal excision (TME) for T1-2, N0
tumours can achieve a local recurrence rate of less than
1%.6
However, TME is a major undertaking and can associate
with significant morbidity and even mortality.7-9 In
addition, the quality of life may be impaired in terms of
bowel, bladder and sexual function disturbances.10-12
In the past two decades, locoregional treatment for early
rectal cancers has been advocated with much less
morbidity and better functional outcomes. In certain
groups of patients i.e. T1 rectal cancers with favourable
characteristics, the oncological outcomes can actually be
comparable to conventional radical surgery.13-15
The advent of transanal endoscopic microsurgery (TEM)
technique that was developed and described by Prof.
Gerhard F. Buess in the early 80's further flourished the
use of locoregional treatment of early rectal cancers in the
last 15 years.
TEM has been introduced into Hong Kong since 1995.
Local experience also echoes the findings in those
literature reviews16. However, its clinical application in
Hong Kong is still not popular. One of the possible
reasons might be the expensive instruments that are
required.
In the past decade, laparoscopic surgery was well
established and equipped in most surgical units in Hong
Kong. By simple modification, a new transanal
resectoscope - Transanal Endoscopic Operation (TEO)
was introduced by incorporating with readily available
laparoscopic instruments to make it as effective and
precise as compared with TEM.
Introduction
Transanal Endoscopic Operation (TEO) is a modification
of the well established procedure - Transanal Endoscopic
Microsurgery (TEM) which was first introduced by
Professor Buess17-21. This is a form of transanal excision
for rectal tumours, either benign or malignant. A
specially designed rectoscope (8 or 15cm in length, 4cm
in diameter) incorporated with ordinary laparoscopic
imaging system allows precise dissection under
magnifying view (Figure 2,3). TEO is performed with
constant carbon dioxide insufflation. High definition
optics guarantee brilliant view and specific
instrumentation allows precise dissection, full thickness
resection and suturing of the defect. Furthermore, the
more ergonomic operating position can save surgeons
from occupational health hazards.
Experience from TEM in the treatment of early rectal
cancers demonstrates that T1 cancers with good or
moderate differentiation completely resected have
recurrence rate of less than 5% and with a good chance
for salvage radical re-operation22-27. In experienced
centres, the recurrence rate of adenoma is low (3-4%).
There is a demonstration for the high preciseness of the
procedure and much lower recurrence than after any
other local procedure (recurrence rates after resection by
using a retractor is around 30% in the literature) 28-31.
Transanal Endoscopic Operation (TEO)
Dr. Kevin KK YAU
Dr. Kevin KK YAU
Consultant Surgeon, Department of Surgery, Pamela Youde Nethersole Eastern Hospital
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Figure 1:Incidence Trend of Colorectal Cancer from 1997-
2006 (Source: Hong Kong Cancer Registry, Hospital
Authority)
Figure 2: TEO instruments. Noted the angulated tip
design allow precise manipulation of tissue within
narrow working space.
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TEO is well tolerated by patients with no external
wound, less pain, less life-threatening complications and
shorter hospital stay. Stoma is not required as the anal
sphincter is saved.
Indication of TEO
Early Stage Rectal Tumours
TEO has emerged as an improved method of transanal
excision of neoplasms because its enhanced visibility,
superior optics, and longer reach permit a more complete
excision and precise closure (Figure 4).
Proper case selection is mandatory for the success of TEO
in the curative treatment of early rectal carcinomas.
Endorectal ultrasonography allows very precise and
accurate tumour and regional lymph node staging
(Figure 5). Only patients with sonographic stage of T1,
i.e. without invasion of muscularis propria, will be
suitable for this procedure for curative intent. TEO
treatment of T1 rectal cancers is safe and can achieve low
local recurrence and high survival rates as compared
with conventional local excisional surgery22-27.
Large Villous Adenomas
Large villous tumours frequently occur in the rectum
and have a significant incidence of harbouring truly
invasive carcinomas. The presence or absence of
malignancy and its subsequent tumour staging can only
be made by complete full thickness excision. Presence of
invasive carcinoma on pathologic examination requires
further surgical intervention appropriate for that
diagnosis.
Recurrence depends on the technique used for tumour
removal. It is highest for fulguration and local excision
and lowest for operations that excise all or part of the
rectum. Because most recurrences can be managed with
local measures and the risk of malignancy in recurrences
is relatively low, the procedure with which the tumour
can be completely excised with the least morbidity
should be used.
TEO allows full thickness excision with precision and the
rectal defect can be closed with absorbable stitches
(Figure 6). Most lesions in the mid and low rectum can be
dealt with by this technique.
Figure 3: Operative view of Transanal Endoscopic
Operation. Noted the ergonomic position of surgeon and
the clear endoluminal view.
Figure 6: Large villous adenoma up to 7cm size was
resected by TEO.
Figure 5: Endorectal Ultrasound examination confirmed
T1 early rectal cancer.
Figure 4: Precise full thickness excision of early rectal
cancer is important for the tumor T-staging.
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Rectal Carcinoid Tumors
Rectal carcinoids are becoming more common. This is
probably related to the increase use of colonoscopic
examination for those patients who have lower
gastrointestinal tract symptoms.
Endorectal ultrasonography is useful in determining
the size and depth of penetration of the tumours and
for detecting local lymph node metastases. Tumours of
less than 10 mm in size that have not infiltrated the
submucosa can be removed easily by TEO with
curative intent. However, when invasion of lymph or
blood vessels or lymph node metastases are found,
radical surgery is still indicated.
Palliative Treatment for Advanced Rectal
Carcinomas
Palliative treatment is important to improve the
quality of life in patients with locally advanced or
metastatic rectal tumours that preclude curative
treatment. Stoma can temporarily relieve symptoms of
intestinal obstruction. However, local symptoms such
as tumour bleeding and tenesmus can be very
frustrating. By using TEO, local excision of T2 or T3
tumours is possible in selected patients under regional
anaesthesia (Figure 7) and can significantly relieve
symptoms including obstruction, bleeding or
tenesmus in the remaining life time of these terminal
patients.
Extended Indication of TEO: Natural Orifice
Trasluminal Endoscopic Surgery (NOTES)
Laparoscopic colectomy has become more and more
popular nowadays and some centres even take it as
routine surgery for left side colonic tumours. However,
specimen retrieval still necessitates a mini-laparotomy
wound which may result in more wound related
complications such as pain, bleeding and infection.
Recently, our centre has published a new surgical
technique of 'Endo-Laparoscopic Colectomy' without
mini-laparotomy, where specimen retrieval and
colorectal anastomosis can be safely achieved with the
use of TEO device32 (Figure 8). This technique is
suitable for patients with tumour size less than 4cm in
left side of the colon or upper rectum. Initial results are
quite promising.
Conclusion
Although a formal government-led screening
programme for colorectal cancers has not been
promulgated in Hong Kong, people are now aware of
the increasing trend in colorectal cancers through
different media. More and more patients will prefer to
have colonoscopy done when they get lower
gastrointestinal tract symptoms. Consequently, more
pre-malignant and small sized rectal lesions will be
found. Among these patients, certain highly selected
cases will definitely be benefited from TEO.
Nevertheless, the author doesn't believe that TEO will
be the single panacea to solve all problems. We have
different modalities of treatment options available
nowadays: from medical to surgical treatment and from
conventional open radical surgery to minimally
invasive surgery. The most important point is to tailor-
make our treatment strategy so that our patients can
fully enjoy the benefit of the medical advancement in
the new era. With this TEO device, both the surgeon
and the patient are now given a choice!
Figure 7: Palliative resection of T3 rectal tumour by TEO
Figure 8. The resected colon was being delivered out of the
TEO so that a mini-laparotomy wound can be avoided.
Hong Kong Cancer Stat 2006, Hong Kong Cancer Registry, Hospital
Authority, 2008. Hong Kong Special Administrative Region, China.
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(See P.29 for answers)
1. What is your diagnosis or possible differential diagnoses?
2. How will you confirm your clinical diagnosis?
3. Name one investigative test which is relevant to her skin
problem and her weight loss.
4. What is the treatment for her skin condition?
This 45-year-old woman complained of these non-itchy non-
tender skin lesions at her shins for three years (Fig.a&b). The
skin lesions increased in size in both shins progressively
despite various topical creams she bought over the counter.
In recent months, she also lost 10 pounds in weight.
Questions:
Fig.a Necrobiosis lipoidica
Fig.b Necrobiosis lipoidica
Dr. Ka-ho LAU
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Introduction
The benefits of laparoscopic approach in gynaecological
surgery are well recognised.1 Compared with
conventional open surgery, it is associated with small
incisions and better cosmetic results, less blood loss, less
tissue trauma, less post-operative pain, shorter hospital
stay, faster recovery with an earlier return to work and
full activity, and fewer post-operative adhesion
formation. The major concern about laparoscopic
myomectomy (LM) is suboptimal tissue apposition
during repair of myometrial defects leading to uterine
rupture in subsequent pregnancies. However, if the
myometrial repair is performed with the same degree of
care as it would be at open myomectomy, there appears
to be no reason why the rate of uterine rupture should be
higher after LM.2 An Italian multicentre study on
complications of LM provided prospectively acquired
data on the complications associated with 2050 LMs. The
favourable clinical results and extremely low conversions
rate of 0.34% suggested that LM is a safe and reliable
procedure, even in the presence of multiple or enlarged
myomas.3 We are now entering the age of robotic
surgery. At the moment, though robotic myomectomy
leads to less blood loss and shorter hospital stay when
compared with the conventional approach, it is more
costly.4 Moreover, most myomectomies can be
accomplished laparoscopically without the need for
robotic technology.
Owing to the inherent characteristics of laparoscopic
surgery including decreased tactile sense, limited
direction of access towards targets and degrees of
freedom of movement, difficulties may be encountered
during the performance of LM. The technical aspects of
LM are discussed in this article.
Case Selection
Correct case selection is vital to the success of LM. LM is
suitable for a single fibroid smaller than 10cm in
diameter and, for multiple fibroids, the sum of diameters
should not exceed 15cm.5 In the case of big fibroids,
preoperative fibroid shrinkage with Gonadotrophin
releasing hormone analogues (GnRHA) may be used so
that the selection criteria can be met. Use of GnRHA
prior to myomectomy reduces intra-operative blood loss,
too.6 However, it may lead to blurring of the surgical
planes and hence difficulty in enucleation of the fibroids.
Pre-operative Mapping
Because of reduced tactile sense, small intramural
fibroids may not be located during laparoscopy.
Preoperative mapping with ultrasonogram, and even
magnetic resonance imaging (MRI), is very important so
that small fibroids are not missed during the operation.7
MRI is also particularly useful in differentiating fibroids
from adenomyomas. Laparoscopic resection of
adenomyomas can be a nightmare for the gynaecologic
laparoscopist since there is no capsule or a clear margin
for dissection and therefore the resection may be difficult
and incomplete.
Basic Techniques of Laparoscopic
Myomectomy (Figure 1)
Caution should be exercised in positioning the patient.
The hip flexion and abduction should be such that the
trunk-to-thigh angle is approximately 170 degrees and
never more than 180 degrees to prevent nerve injury.8
Steep Trendulenburg position is adopted to allow the
bowels to fall away from the pelvic organs. Uterine
manipulator may be used to optimise exposure and
stabilise the uterus.
Intra-umbilical port is used to introduce the laparoscope.
Many surgeons use the diamond-shaped port placement
where the accessory ports are sited in the bilateral lower
quadrants and suprapubic region. The chief surgeon then
works through the ipsilateral lower quadrant port and
supra-pubic ports. The author employs the so-called
ultra-lateral port site placement by creating side ports in
the left and right lower quadrants just medial to the
anterior superior iliac spines, and left paramedian region
under direct laparoscopic guidance. The right-handed
surgeon works through the left side ports while the
assistant holds the laparoscope and works through the
right side port. Their positions may be exchanged if the
surgeon is left-handed. Ultra-lateral port siting is less
tiring for the surgeon since it allows the surgeon's upper
and forearms to be adducted and the wrist and hand
motion to be natural. It also allows the laparoscopic
instruments to approach the target in a horizontal plane
as in open surgery, eliminating the fulcrum effect.9
Besides, it avoids injuries to the inferior and superficial
epigastric vessels.
The maximum volume of pitressin (20units diluted in
100ml normal saline) in millilitres that can be used is
approximately equal to the patient's body weight in
kilograms. After injecting the vaso-constrictor, the author
uses the ultrasonic scissors to resect the uterine fibroids.
The direction of line of uterine incision is designed so as
to facilitate the subsequent myometrial repair. One
should always leave sufficient serosa and myometrium,
Technical Pearls in Laparoscopic Myomectomy
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even overlapping layers, to avoid excessive tension on
the sutures.
After enucleation of the fibroids, layered repair of the
uterine defects is carried out using vicryl o sutures.
Where the endometrial cavity is entered, vicryl 3o suture
is used for closure. Events leading to uterine scar
dehiscence in subsequent pregnancies are thought to
include suboptimal suturing of the uterine incision
and/or impaired wound healing from extensive use of
coagulation or any tissue-destroying modality. There are
no data suggesting that any one suturing technique is
superior in minimising this risk-whether continuous or
interrupted sutures are placed, whether the knots are
tied intracorporeally or extracorporeally, or whether the
suturing is done by hand or a suturing device. Sutures
with shorter half-lives or ones that may lose strength in
the presence of infection (e.g. chromic) should most
likely not be used. All in all, careful closure of the uterine
incision with minimal coagulation is most critical.10
The specimens are retrieved through one of the
accessory ports after morcellation. Alternatively, the
specimens may be put into an endobag which is then
delivered through a posterior colpotomy. In addition,
all fibroid fragments should be meticulously removed
after morcellation to prevent the rare complication of
parasitic peritoneal leiomyomatosis.11
traced on the anterior abdominal wall and dissection is
carried out cephalad to identify first the superior vesical
artery and then the uterine artery.12 The uterine arteries
are then obliterated with bipolar electrocautery or
ligated. However, this method is only suitable for those
who desire no further pregnancies since the effect of
bilateral uterine artery obliteration on the subsequent
pregnancies is not known.
Big Uterus
For a big uterus, supra-umbilical, instead of intra-
umbilical, port should be used for the introduction of
the laparoscope-usually the port is sited 2cm above the
uterine fundus so that there is sufficient space for
optimal visualisation. Enucleation and morcellation of
big fibroids can be very demanding and tedious. Sinha
et al described a method to deal with a large fibroid by
morcellating the fibroid while it is still attached to the
uterus and enucleating only to about one-fourth of its
circumference.13 As electromechanical traction by the
claw forceps causes progressive separation of the
myoma from the uterus, morcellation completes the
enucleation while removing the myoma from the
abdominal cavity. Caution should be exercised during
morcellation not to damage the normal myometrium.
Cervical Fibroids
Dissection of the bladder is usually necessary before
myomectomy for fibroids at the cervical region. In order
to avoid bladder injury, it is important to keep the
dissection close to the uterus and point the tip of the
scissors towards the uterine side. The 30 degree
laparoscope is very useful in visualising fibroids in such
an awkward position as the cervical fibroids. The ability
to perform suturing with both hands is vital for proper
repair of the uterine defect at the cervical region.
Broad Ligament Fibroids
Broad ligament fibroids are situated in the pelvis where
the ureters lie. The ureters may be at jeopardy if they
are not clearly visualised. Ureteric dissection should
therefore always be carried out before attempts to
remove the uterine fibroids. The ureter in the pelvic
side wall can be dissected by one of the following three
approaches. The pelvic approach consists of visualising
the ureter directly in its natural position on the pelvic
side wall through the peritoneum of the broad
ligament. The peritoneum is incised lateral to the ureter
which is then dissected inferiorly to close to the uterus.
In the cephalad approach, the peritoneum just medial to
the infundibulopelvic ligament is opened to expose the
ureter at the pelvic brim. On the left side, sometimes,
the congenital adhesions of the sigmoid colon have to
be divided. Once the ureter has been identified, it is
then progressively dissected off the medial leaf of the
broad ligament until the uterine vessels are reached. In
the caudad approach, the obliterated hypogastric artery,
which is easily identified on the anterior abdominal
parietal peritoneum, is dissected superiorly. The superior
vesical artery is encountered before the origin of the
uterine artery is located from the internal iliac artery. The
ureter is then easily identified underneath the uterine
artery in the medial border of the pararectal space. After
Patients with Contraindications to the
Use of Vaso-constrictors
In patients with contra-indications to vaso-constrictors,
interruption of the uterine blood supply is used to
reduce intra-operative blood loss. The uterine artery can
be traced by first identifying the ureter and then tracing
along it distally. The uterine artery is then seen lying
above the ureter. The uterine artery may also be
identified by retrograde dissection of the obliterated
hypogastric artery-the obliterated hypogastric artery is
Figure 1
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the ureter has been identified, the subsequent resection of
the fibroids is usually easy and, many a times, suturing is
not needed because the fibroids are pedunculated.
Management of Adenomyomas
Detected Intra-operatively
Despite tremendous efforts to differentiate uterine
fibroids from adenomyomas, one should always be
prepared to perform an incidental laparoscopic
adenomyomectomy. Takeuchi et al performed
adenomyomectomy by first making a transverse incision
through the adenomyotic tissue down to the
endometrium. The adenomyotic tissue was then excised
by slicing in layers with a monopolar needle on 70W
incision mode. They counteracted the substantial loss in
the muscle layer after adenomyomectomy by overlapping
the normal muscle layer on the serosal membrane side
and below the incision line as serosal flaps.14
Laparoscopic hysterectomy is another option for the
incidental finding of adenomyosis during the attempt to
extirpate uterine fibroids. Preoperative counselling for
possible hysterectomy is of paramount importance and
so is the ability to carry out laparoscopic hysterectomy.
Conclusions
LM is a feasible and safe alternative to the conventional
open myomectomy in many instances. It should start
with careful case selection and meticulous preoperative
mapping. Optimal tissue apposition with good
laparoscopic suturing skill is the key to a successful LM.
One should also learn the techniques to deal with
difficult situations such as patients with
contraindications to vasoconstrictors, big uteri, cervical
and broad ligament fibroids. Furthermore, one should be
prepared to perform laparoscopic adenomyomectomy
and even laparoscopic hysterectomy in all cases of
intended LM.
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Foundation News
Smoking Cessation Carnival 
Sponsored by Rotary Club of Hong Kong Northwest and co-organised with Aplichau Kaifong Primary School (AKPS) and Hong 
Kong Shuttlecock Association Limited (HKSA), a Smoking Cessation Carnival - 扶老攜幼踢走支煙 was held at Aplichau Kaifong 
Primary School in Aplichau, Aberdeen on Saturday, 16th May 2009.  The event was a success with a turnout of around 400.
We were honored to have Dr. Ronald LAM, Head of Tobacco Control Office, Department of Health; Mr. Roger LEE, Assistant 
Governor (Area 5) of Rotary International District 3450; Mr. Alec TSANG, President of Rotary Club of Hong Kong Northwest; 
Professor Eva LAI, Director of English Language Centre, United International College, Beijing Normal University - Hong Kong 
Baptist University; Ms. FUNG Pik Yee, Headmistress of Aplichau Kaifong Primary School;  Dr. Dawson FONG, President of The 
HKFMS Foundation Limited; Dr. Maureen WONG, Chairlady of the organizing committee officiated at the opening ceremony.
News from Member Societies
Hong Kong Society of Transplantation
Updated office-bearers for the year 2009-2010 are as follows: President: Prof. Philip Kam-tao LI; Honorary 
Secretary: Dr. See-ching CHAN; Honorary Treasurer: Dr. Ming-kwong YIU
HKSUM was registered as a company limited in 2006, and exemption under Section 88 of the Inland Revenue 
Ordinance was granted in 2007. 
HKSUM consists of radiologists, obstetricians & gynaecologists, and cardiologists. Radiographers, nurses and 
other professionals are welcome to join HKSUM as associate members. At present, we have 36 members and 18 
associate members. 
The objectives of HKSUM are to:
(a) advance the art and science of ultrasound in medicine and research 
(b) promote good medical ultrasound practice  
(c) promote postgraduate training in ultrasound in medicine 
HKSUM has been holding scientific meeting regularly since 2006. Members can enjoy a discount in the 
registration fee for the World Federation for Ultrasound in Medicine and Biology (WFUMB) Congress, receive 
information from WFUMB and the Asian Federation of Societies For Ultrasound in Medicine and Biology 
(AFSUMB), and apply for the sponsorhsip offered by AFSUMB. Information is posted on our web site 
www.hksum.com. Online CME activities will be provided soon. 
HKSUM will act as a body for the purpose of consultation in matters of education or public interest related to 
medical ultrasound. Dr Lilian Leong, Dr. William So, Prof. CP Lau, Dr. Adolphus Chau is our spokesman for 
general ultrasound, O&G ultrasound, adult cardiology, and paediatric cardiology respectively. 
KY Leung
President
The FMSHK would like to send its congratulations to the new office-bearers and look forward to 
working together with their societies. 
Welcome New Members
Hong Kong Society for Ultrasound in Medicine Limited
Office-bearers for the year 2009-2010 are as follows: President: Dr. K.Y. LEUNG; Hon. Secretary: Dr. William 
W.K. TO; Hon. Treasurer: Dr. Ernest H.Y. NG
The FMSHK would like to welcome Hong Kong Society for Ultrasound in Medicine Limited as 
associate member of the Federation. 
an affiliated member of 
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Following the addresses delivered by our distinguished guests, in no time at all, Ms. Purple Lee (紫昕姐姐), engaged and excited 
the young audience with her iconic medley of children songs. The lively performance from AKPS school choir further spiced up 
the event with the cartoon-styled theme song "齊齊來踢走支煙" specifically composed by Dr. Hilda WONG. 
To help kick the bad habit of smoking -"踢毽,踢毽,踢走支煙"- shuttlecock was used both as a medium and pun to bring out the 
essence of the programme. Training classes delivered by the HKSA prior to event day paved road to revive interest among students 
in that ancient yet timeless and healthy sport. The subsequent amazing onstage performance by HKSA and AKPS students only 
bore testimony to their enthusiasm, alongside the vibrant rhythms and lyrics of our theme song that reverberated around.
Finally, a health talk to imprint parents and kids with importance and tips to stay away from smoking was delivered, before the 
crowd swarmed to the playground for more fun, information, gifts and souvenirs at the specially-themed game booths, 
exhibition boards and health check stations. Hopefully, the action-packed event through shuttlecock, with our message of "NO 
SMOKING" will etch on the mind of those youngsters and their families.
Medical Diary of July
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19 Ms. Dora HOTel: 2527 8285Photo Sharing SessionOrganised by: The Hong Kong Medical Association, Venue: The HKMA Dr. Li Shu PuiProfessional Education Centre, 2/F., Chinese Club Building, 21-22 Connaught Road
Central, Hong Kong
2:00 pm
SUN
18 Mr. Gary WONGTel: 3513 4821HKMA - KECN & UCH - Management of Poisonous Bite & StingOrganised by: HKMA KECN & UCH, Chairman: Dr. LAU Fei Lung, Speaker: Dr. CHANYiu Cheung, Venue: Lecture Theatre, G/F, Block P, United Christian Hospital, Kowloon
Hong Kong St. John Ambulance
Association
Tel: 2530 8020
Email: assn@stjohn.org.hk
Web site: http://www.hku.hk/surgery
Pre-Hospital Trauma Life Support (PHTLS) Provider Course
Organised by: Department of Surgery, Queen Mary Hospital; Hong Kong Chapter of the
American College of Surgeons & Hong Kong St. John Ambulance Association, Venue: St.
John Ambulance Association, 2 Macdonnell Road, Mid-Levels, Hong Kong
Forum Secretary
Tel: 2855 4885 / 2855 4886
Fax: 2819 3416
E-mail: hksf@hkucc.hku.hk
Web-site:
http://www3.hku.hk/surgery/forum.php
Hong Kong Surgical Forum - Summer 2009: Minimally Invasive Surgery
Organised by: Department of Surgery, Li Ka Shing Faculty of Medicine, The University of
Hong Kong; Queen Mary Hospital & Hong Kong Chapter of American College of
Surgeons, Venue: Underground Lecture Theatre, New Clinical Building, Queen Mary
Hospital, Pokfulam, Hong Kong
1:30 pm
(26)
SAT
16 Ms. Christine WONGTel: 2527 8285HKMA Annual General MeetingOrganised by: The Hong Kong Medical Association, Chairman: Dr. H.H. TSE, Venue:HKMA Head Office, 5/F., Duke of Windsor Social Service Building, 15 Hennessy Road,
Hong Kong
9:00 pm
THU
Ms. Sandra CHU
Tel: 2387 8555
1 CME Point
1:30 pm
8:00 pm - 10:00pm
7 TUE
8 WED
HKMA Tai Po Community Network CME - When and How to Use Insulin?
Organised by: HKMA Tai Po Community Network, Speaker: Dr. KONG Pik Shan
Alice, Venue: Tai Po
Ms. Paulina TANG
Tel: 2527 8898 Fax: 2865 0345
FMSHK Officers' Meeting
Organised by: The Federation of Medical Societies of Hong Kong, Venue: Gallop, 2/F.,
Hong Kong Jockey Club Club House, Shan Kwong Road, Happy Valley, Hong Kong
7:30 am
2:00 pm
Dr. Y.C. PO
Tel: 2990 3788 Fax: 2990 3789
2 CME Points
HK Neurosurgical Society Monthly Academic Meeting - Pineal Tumor
Organised by: Hong Kong Neurosurgical Society, Chairman: Dr. HUNG Kwan Ngai,
Speaker: Dr. TSE Yat Hang, Venue: Seminar Room, G/F, Block A, Queen Elizabeth
Hospital, Kowloon
Miss Alice TANG
Tel: 2527 8285
HKMA - Shatin Doctors Network - Certificate Course on Osteroporosis
Organised by: HKMA - Shatin Doctors Network, Venue: Shatin
8:00 pm Ms. Candy YUEN
Tel: 2527 8285
HKMA Orchestra Rehearsal
Organised by: The Hong Kong Medical Association, Venue: Pui Ching Education Centre
Miss Alice TANG
Tel: 2527 8285
5 SUN Ms. Dora HOTel: 2527 8285
Islands Hopping Tour in Yan Chau Tong
Organised by: The Hong Kong Medical Association, Venue: Yan Chau Tong
Ms. Dora HO
Tel: 2527 8285
Joint Professional Tennis Tournament
Organised by: The Hong Kong Medical Association, Venue: Chinese Recreation Club
2:00 pm
10:00 am
6:00 pm
4 SAT
Taoyuan Project Pilot Tester Sharing Session
Organised by: The Hong Kong Medical Association, Venue: HKMA Wanchai
Premises, 5/F., Duke of Windsor Social Service Building, 15 Hennessy Road, Wanchai,
Hong Kong
14 Ms. Paulina TANGTel: 2527 8898Fax: 2865 0345
FMSHK Executive Committee Meeting
Organised by: The Federation of Medical Societies of Hong Kong, Venue: Council
Chambers, 4/F., Duke of Windsor Social Service Building, 15 Hennessy Road, Wanchai,
Hong Kong
8:00 pm - 10:00 pm
9
11
12
THU
Miss Viviane LAM
Tel: 2527 8452
1 CME Point
HKMA Structured CME Programme with Hong Kong Sanatorium & Hospital Year
2009 - Current Update on Shoulder Pain
Organised by: The Hong Kong Medical Association and Hong Kong Sanatorium &
Hospital, Chairman: Dr. KONG Kam Fu James, Speaker: Dr. WONG Wai Kwok Jimmy,
Venue: The HKMA Dr. Li Shu Pui Professional Education Centre, 2/F., Chinese Club
Building, 21-22 Connaught Road Central, Hong Kong
Secretariat
Tel: 2572 9255 Fax: 2838 6280
3 CNE Points
Care at the Moment of Death (Code no. SE-CMD-0902)
Organised by: College of Nursing, Hong Kong, Speaker: Ms. SHIU Sin Man Vicky
2:00 pm
6:30 pm - 9:30 pm
Ms. Clara TSANG
Tel: 2354 2440
2 CME Points
Refresher Course for Health Care Providers 2008/ 2009 - Approach to elderly with
frequent falls
Organised by: The Hong Kong Medical Association and Our Lady of Maryknoll
Hospital, Chairman: Dr. CHEUNG Pui Shan, Speaker: Dr. LAU Sze Ting, Venue:
Training Room II, 1/F., OPD Block, Our Lady of Maryknoll Hospital, 118 Shatin Pass
Road, Wong Tai Sin, Kowloon, Hong Kong
2:30 pm
Ms. Dora HO
Tel: 2527 8285
Joint Professional Snooker Tournament
Organised by: The Hong Kong Medical Association, Venue: General Snooker Club
2:00 pm
Miss Viviane LAM
Tel: 2527 8452
3 CME Points
HKMA Certificate Course on Family Medicine 2009
Organised by: The Hong Kong Medical Association, Speakers: Prof. WONG Yeung
Shan Samuel & Dr. LAM Tzit Yuen David, Venue: Queen Elizabeth Hospital, Kowloon
2:00 pm
TUE
Ms. Christine WONG
Tel: 2527 8285
3 FRI
Department of Surgery, Hong
Kong Sanatorium & Hospital
Tel: 2835 8698 Fax: 2892 7511
1 CME Point (Active)
Joint Surgical Symposium - Breast Cancer Biology and Its Application
Organised by: Department of Surgery, The University of Hong Kong and Hong Kong
Sanatorium & Hospital, Chairman: Prof. Simon LAW, Speakers: Dr. Ava KWONG &
Dr. CHAN Yu-Wai, Venue: Hong Kong Sanatorium & Hospital, Hong Kong
8:00 pm
8:00 am - 9:00 am
2 THU
HKMA Council Meeting
Organised by: The Hong Kong Medical Association, Chairman: Dr. H.H. TSE, Venue:
HKMA Head Office, 5/F., Duke of Windsor Social Service Building, 15 Hennessy
Road, Hong Kong
Date / Time Function Enquiry / Remarks
(15,22,29)
SAT
SUN
Calendar of Events
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Meetings
International Symposium on Hepatology 2009 / 22nd Annual Scientific Meeting
Organised by: The Hong Kong Association for the Study of Liver Diseases, Venue: Hong Kong Convention and Exhibition Centre,
Enquiry: Ms. Melissa LEUNG, CMPMedica Pacific Limited, Tel: 2116 4348, E-mail: melissa.leung@asia.cmpmedica.com
8/11/2009
Courses
Advanced Trauma Life Support (ATLS) Student Course
Organised by: Department of Surgery, Queen Mary Hospital & Hong Kong Chapter of the American College of Surgeons, Venue: The
Jockey Club Skills Development Centre, C3, Main Block, Queen Mary Hospital, Pokfulam, Hong Kong, Enquiry: Course Administrator,
Tel: 2855 4885 / 2855 4886, Fax: 2819 3416, Email: hnsrg@hkucc.hku.hk, Web site: http://www.hku.hk/surgery
Certificate Course on Clinical Teaching and Assessment (Code no: TC-CTA-0903)
Organised by: College of Nursing, Hong Kong, Enquiry: Secretariat, Tel: 2572 9255, Fax: 2838 6280, 24 CNE points
Certificate Course on Interpretation of Electrocardiography (Code no: TC-ECG-0902)
Organised by: College of Nursing, Hong Kong, Enquiry: Secretariat, Tel: 2572 9255, Fax: 2838 6280, 24 CNE points
Advanced Trauma Care for Nurses (ATCN) Provider Course
Organised by: Department of Surgery, Queen Mary Hospital & Hong Kong Chapter of the American College of Surgeons, Venue: The
Jockey Club Skills Development Centre, C3, Main Block, Queen Mary Hospital, Pokfulam, Hong Kong Enquiry: Course Administrator
Tel: 2855 4885 / 2855 4886 Fax: 2819 3416 Email: hnsrg@hkucc.hku.hk Web site: http://www.hku.hk/surgery
Advanced Medical Life Support (AMLS) Provider Course
Organised by: Department of Surgery, Queen Mary Hospital & Hong Kong Chapter of the American College of Surgeons, Venue: The
Jockey Club Skills Development Centre, C3, Main Block, Queen Mary Hospital, Pokfulam, Hong Kong, Enquiry: Course Administrator,
Tel: 2855 4885 / 2855 4886, Fax: 2819 3416, Email: hnsrg@hkucc.hku.hk Web site: http://www.hku.hk/surgery
14-16/8/2009,
11-13/9/2009,
20-22/11/2009
15,22,29/8/2009
2,9/9/2009
15,22,29/8/2009
2,9, 23/9/2009
11-12/9/2009,
20-21/11/2009
12-13/12/2009
Upcoming Certificate Courses of the Federation of Medical Societies of Hong Kong
6 Aug 09 - 10 Sep
09 (Every Tur)
12 - 26 Sep 09
(Every Sat)
2 Sep 09 - 7 Oct 09
(Every Wed)
Healthcare Professionals
Professionals in Clinical Practice
General Practitioners & Allied
Health Professions
9 CNE Points ; CME
Accreditation in application
6 CNE Points ; CME
Accreditation in application
9 CNE Points ; CME
Accreditation in application
Certificate Course on Wilderness
Medicine
Certificate Course on Clinical Ethics
in Practice
Certificate Course on Clinical
Ophthalmology
C141
C147
C148
ate Course No Target ParticipantsCourse Name CME/CNE
Members' Benefits
The Federation of Medical Societies of Hong Kong
The Federation, in cooperation with Kingsway Concept Limited, offers a
discount on petrol and diesel purchases of HK$0.9/litre from Caltex, Shell,
Esso and Sinopec to members and their families of all Ordinary and
Associate member societies under the Federation. Please contact our
Secretariat on 2527 8898 and info@fmshk.org or Kingsway Concept Limited
on 2541 1828 and kingswayconcept@yahoo.com for further details and terms
for this offer.
28 Ms. Sandra CHUTel: 2387 8555HKMA - YTM CN - When & How to Start InsulinOrganised by: HKMA YTM CN, Chairman: Dr. C.P. HO, Speaker: Dr. IP Tai Pang,Veune: Eaton Hotel, Kowloon
1:30 pm
TUE
Ms. Paulina TANG
Tel: 2527 8898 Fax: 2865 0345
HKFMS Foundation Meeting
Organised by: The Federation of Medical Societies of Hong Kong, Venue: Council
Chambers, 4/F., Duke of Windsor Social Service Building, 15 Hennessy Road, Wanchai,
Hong Kong
8:00 pm - 10:00 pm
Date / Time Function Enquiry / Remarks
26 Miss Viviane LAMTel: 2527 84522 CME Points
HKMA Structured CME Programme with PMH Year 2009 (6) - i) Common Upper
Limb Orthopaedic Problems ii) Common Orthopaedic Foot Problems
Organised by: The Hong Kong Medical Association, Speakers: Dr. WONG Hin Keung
& Dr. SIU Kwai Ming, Venue: G8 Hall, Princess Margaret Hospital, Kowloon
2:00 pm
SUN
23 Dr. James C.M. HO / Dr. JohnnyW.M. CHANTel: 2855 4999 Fax: 2872 5828
1 CME Point
(1) Bubbles, Bubbles, Bubbles (2) TB or not TB
Organised by: Hong Kong Thoracic Society/ACCP(HK & Macau Chapter),
Chairpersons: Dr. YU Wai Cho & Dr. WONG Mo Lin, Speakers: Dr. Jones KWOK, Dr.
YEUNG Yiu Cheong & Dr. YAU Pak Yuen Anthony, Venue: LG1, Lecture Room,
Ruttonjee Hospital, Wanchai, Hong Kong
6:30 pm - 8:00 pm
THU
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Answer to Dermatological Quiz
These multiple 0.5 to 3 cm annular violaceous red-
brownish/yellowish plaques with palpable peripheral
rims and yellow-brown atrophic centres that contained
telangiectasia affecting quite symmetrically over
patient's shins. The skin lesion, together with a history of
recent weight loss, is compatible with necrobiosis
lipoidica (NL). NL is three times more common in
women than in man with an average age of onset at 30.
About 85% of NL involves leg exclusively and 50% have
four to eight plaques. Ulceration occurs in 35% and is
often precipitated by trauma. Other differential
diagnoses of the annular infiltrative eruption on the shin
may include granuloma annulare, pyoderma
gangrenosum, annular elastolytic giant cell granuloma
and rarely sarcoidosis.
The definitive diagnosis of necrobiosis lipoidica requires
clinico-pathological correlation. Skin biopsy shows the
presence of palisading granuloma with histiocytic cells
and lymphocytes with their long axes arranged
perpendicular to large central areas of necrobiosis
containing altered bent, curled and disarrayed collagen
in the reticular dermis. In typical presentation, clinical
diagnosis can be made with compatible clinical
morphology and history to save the patient from skin
biopsy on the necrobiotic area which may be difficult to
heal.
Fasting blood sugar, and if indicated oral glucose
tolerance test, is warranted in our patient with NL with
recent weight loss. The proportion of NL patients with
diabetes mellitus varies from 14 to 65%. Of these diabetic
patients, sixty percent of patients have history of
diabetes mellitus prior to the onset of skin disease and
25% develop skin lesions with the onset of diabetes.
Fifteen percent of these patients with skin manifestations
precede the onset of diabetes.
The treatment of NL is largely anecdotal and often
unsatisfactory. First line therapy includes potent topical
corticosteroids for early lesions and intralesional steroids
injected into the active borders of established lesions.
Short course of oral corticosteroids was reported to be
effective in small case series. Other treatments reported
with some success include topical tretinoin, oral
niacinamide and oral cyclosporin. Surgical excision with
split thickness skin grafting may be necessary for
refractory ulcerative NL.
1.
2
3.
4.
Dr. Ka-ho LAU
Yaumatei Dermatology Clinic, Social Hygiene Service
MBBS(HK), FRCP(Glasg), FHKCP, FHKAM(Med)

